Advertisement
Screener

Neurogene Inc. (NGNE) Finance Lease, Liability, Undiscounted Excess Amount

2.5 / 5 stars · 25/51 Roast Me

Neurogene Inc. Finance Lease, Liability, Undiscounted Excess Amount

Neurogene Inc. (NGNE) had Finance Lease, Liability, Undiscounted Excess Amount of $1.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-24.

Financial Statements › Notes › Leases

us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount · last filed 2026-03-24

  • 2025-12-31: Finance Lease, Liability, Undiscounted Excess Amount $1.00K.
  • 2024-12-31: Finance Lease, Liability, Undiscounted Excess Amount $7.00K.
  • 2024-09-30: Finance Lease, Liability, Undiscounted Excess Amount $9.00K.
  • 2024-06-30: Finance Lease, Liability, Undiscounted Excess Amount $12.00K.
Period endFinance Lease, Liability, Undiscounted Excess Amount
2025-12-31$1.00K
10-K · filed 2026-03-24
2024-12-31$7.00K
10-K · filed 2025-03-24
2024-09-30$9.00K
10-Q · filed 2024-11-18
2024-06-30$12.00K
10-Q · filed 2024-08-09
2024-03-31$13.00K
10-Q · filed 2024-05-10
2023-12-31$16.00K
10-K · filed 2024-03-18
2022-12-31$44.00K
10-K · filed 2023-03-20
2021-12-31$15.00K
10-K · filed 2022-03-01
2020-12-31$23.00K
10-K · filed 2021-03-25
2020-03-31$37.00K
10-Q · filed 2020-05-06
2019-12-31$37.00K
10-K · filed 2020-03-12
2019-09-30$37.00K
10-Q · filed 2019-11-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Shattuck Labs, Inc. (STTK)United States$0.634B-13.30
IMPACT BIOMEDICAL INC. (IBO)United States$0.611B66.47
Aquestive Therapeutics, Inc. (AQST)United States$0.606B-6.67
CorMedix Inc. (CRMD)United States$0.605B3.25
BlossomHill Therapeutics, Inc. (BLSM)United States$0.647B
CytomX Therapeutics, Inc. (CTMX)United States$0.598B-10.25
Monopar Therapeutics (MNPR)United States$0.598B-34.82
Altimmune, Inc. (ALT)United States$0.593B-6.43
ZEVRA THERAPEUTICS, INC. (ZVRA)United States$0.668B14.61
Phathom Pharmaceuticals, Inc. (PHAT)United States$0.572B-8.76